CSIMarket Company Name, Ticker, Customers, else..
 
Benitec Biopharma Inc   (NASDAQ: BNTC)
 

Benitec Biopharma Inc's Suppliers Performance

BNTC's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
BNTC Costs vs Sales of Suppliers Growth

• More on BNTC Suppliers






Benitec Biopharma Inc's Comment on Supply Chain


The company emphasizes the importance of suppliers adhering to current Good Manufacturing Practices (cGMP) and FDA regulatory requirements to prevent regulatory actions such as clinical trial suspensions or product recalls. It recognizes the regulatory oversight by the FDA and other government agencies concerning drug labeling, marketing, and promotion. The company notes the provisions of the Hatch-Waxman Amendments, which allow for limited patent term extensions to compensate for time lost during product development and FDA review. Additionally, it acknowledges the Biologics Price Competition and Innovation Act of 2009, which establishes a pathway for biosimilar products and grants exclusivity to reference biologics.

Benitec Biopharma Inc's Comment on Supply Chain


The company emphasizes the importance of suppliers adhering to current Good Manufacturing Practices (cGMP) and FDA regulatory requirements to prevent regulatory actions such as clinical trial suspensions or product recalls. It recognizes the regulatory oversight by the FDA and other government agencies concerning drug labeling, marketing, and promotion. The company notes the provisions of the Hatch-Waxman Amendments, which allow for limited patent term extensions to compensate for time lost during product development and FDA review. Additionally, it acknowledges the Biologics Price Competition and Innovation Act of 2009, which establishes a pathway for biosimilar products and grants exclusivity to reference biologics.







BNTC's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Benitec Biopharma Inc 460.46 0.06 -45.55 24
SUBTOTAL 0.00 0.00 0.00 -


Sources: Benitec Biopharma Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Benitec Biopharma Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.